Upstate Active Clinical Trials

Study Title:

Prospective Validation of Prostate Biomarkers for Repeat Biopsy:The PRIORITY Study

What is the purpose of the study?

This study is being conducted to evaluate the performance of the ConfirmMDx and SelectMDx tests for Prostate Cancer to identify patients with increased risk for clinically significant disease, and to lower the rate of repeat biopsies.

Upstate Institutional Review Board (IRB) Number:

1022360

Study/Protocol ID:

The PRIORITY Study

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Gennady Bratslavsky, MD

Who can I contact for more information?

Name: Nicholas Carusone, BS
Phone: 315-464-5296
Email: carusonn@upstate.edu

Return to Previous Page || Search Again

Top